Sort
10,829 grants matching “car t”
NextGen - CRI
$1,440,060Catherine Mary Bollard · Children'S Research Institute · OT2 · FY2025 · CA
Admin Core
$1,439,766Carl H. June · University Of Pennsylvania · U54 · FY2019 · CA
Hypoxia signaling in cancer development
$1,436,845Zhengping Zhuang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
STUDY OF LIGNOCELLULOSIC MATERIAL DEGRADATION WITH CARS MICROSCOPY
$1,435,000President And Fellows Of Harvard College · · FY2008 · Department of Energy
Targeting exploitable vulnerabilities in T-cell Lymphoma
$1,434,488Samuel Ng · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$1,428,684Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Digital, Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in Young Transgender Women
$1,425,982Matthew James Mimiaga · University Of California Los Angeles · U01 · FY2021 · AI
Pathogenesis of Secondary Hemophagocytic Lymphohistiocytosis
$1,422,509Joseph Rocco · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Craniofacial Anomalies and Regeneration
$1,420,544Janice Lee · National Institute Of Dental & Craniofacial Research · ZIA · FY2021 · DE
THE OVERALL GOAL OF OUR PROJECT IS THE CONTINUING DEVELOPMENT OF A FRAMEWORK FOR ESTIMATING HIGH-RESOLUTION CARBON STOCKS AND DYNAMICS AND FUTURE CAR
$1,419,104University Of Maryland, College Park · · FY2014 · National Aeronautics and Space Administration
Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders
$1,416,172Julie R Park · Seattle Children'S Hospital · U01 · FY2019 · TR
CAR T cells targeting mesothelin and secreting bispecific antibodies targeting fibroblasts in pancreatic cancer
$1,413,547Marcela Valderrama Maus · Massachusetts General Hospital · UG3 · FY2023 · CA
Combinatorial Engineering of Multicellular Synthetic Immunotherapy Systems
$1,400,954Kyle Gabriel Daniels · Stanford University · DP2 · FY2025 · EB
In vivo HSC gene therapy using a multi-modular HDAd vector for HIV cure
$1,399,750Andre Michael Lieber · University Of Washington · R01 · FY2025 · AI
Targeting TEMs in Preclinical Tumor Models
$1,395,993Bradley D St Croix · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders
$1,395,617Julie R Park · Seattle Children'S Hospital · U01 · FY2022 · TR
New Down syndrome brain organization revealed by single-cell genomics
$1,395,349Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R56 · FY2021 · AG
Nanosystems Biology Cancer Center
$1,393,912James R. Heath · Institute For Systems Biology · U54 · FY2017 · CA
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
$1,392,864Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · P50 · FY2018 · CA
Immunobiology and Immunotherapy of Pediatric Cancer
$1,392,377Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Drug Metabolizing Enzymes In Humans
$1,390,955Joyce Goldstein · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
Accelerate cellular immunotherapy development for treatment of life-threatening childhood disorders
$1,390,827Julie R Park · Seattle Children'S Hospital · U01 · FY2021 · TR
Next Generation GPC2-CARs for Medulloblastoma
$1,390,720Crystal Mackall · Stanford University · UG3 · FY2025 · CA
Next Generation GPC2-CARs for Medulloblastoma
$1,390,720Crystal Mackall · Stanford University · UG3 · FY2024 · CA
Development of Chimeric Antigen Receptors Targeting Multiple Myeloma
$1,387,598James Kochenderfer · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA